ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TEVA Teva Pharmaceutical Industries Ltd

13.88
-0.10 (-0.72%)
Pre Market
Last Updated: 12:23:18
Delayed by 15 minutes
Name Symbol Market Type
Teva Pharmaceutical Industries Ltd NYSE:TEVA NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  -0.10 -0.72% 13.88 28,221 12:23:18

ADRs End Mostly Higher; JD Trades Actively

12/09/2017 10:15pm

Dow Jones News


Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Teva Pharmaceutical Indu... Charts.

International stocks trading in New York closed mostly higher on Tuesday.

The BNY Mellon index of American depositary receipts improved 0.31% to 148.52. The European index increased 0.35% to 138.31. The Asian index improved 0.33% to 171.53. And the emerging-markets index rose 0.20% to 323.22.

Meanwhile, the Latin American index edged down 0.02% to 257.07.

JD.com Inc. (JD) was among those with ADRs that traded actively.

 

JD has hired a top Microsoft cloud-computing executive in China. Samuel Shen, a Microsoft veteran of 24 years and the former general manager of Microsoft's cloud and enterprise business in China, took the job as JD's president of its cloud unit, Beijing-based JD said in a statement Tuesday. ADRs rose 3% to $43.29.

 

ADRs of Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) rose 4.5% to $19.33 a day after the company announced the appointment of Kare Schultz, an industry veteran, as its new CEO. "He brings experience in running a global company, strong ability to execute against a defined strategy and reputation as a straight talker," Alliance Bernstein said in a note. "All key for Teva."

 

HSBC Holdings PLC (HSBC, HSBA.LN, 0005.HK) is seeking a combined $220 million claim from troubled milk producer China Huishan Dairy Holdings Co. China Huishan has received two letters from HSBC stating that it declared all loans, accrued interest and other outstanding amounts under the facility agreement to be immediately due and payable, as one or more events of default have occurred and were continuing. The deadline for payment is within 3 days from Monday, China Huishan said. ADRs rose 0.68% to $48.80.

 

(END) Dow Jones Newswires

September 12, 2017 17:00 ET (21:00 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Teva Pharmaceutical Indu... Chart

1 Year Teva Pharmaceutical Indu... Chart

1 Month Teva Pharmaceutical Indu... Chart

1 Month Teva Pharmaceutical Indu... Chart

Your Recent History

Delayed Upgrade Clock